{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:58:49Z","timestamp":1794535129121,"version":"4.9.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>It is controversial whether or not total thyroidectomy followed by radioactive iodine ablation (RAI-a) (30\u00a0mCi\u2009=\u20091.1\u00a0GBq) is mandatory in intermediate-risk patients with lateral neck lymph node metastasis (cN1b).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective observational study enrolled PTC patients classified preoperatively as the intermediate-risk with cN1b from January 2010 to December 2017 according to the guidelines for thyroid tumors of the Japanese Association of Endocrine Surgeons (JAES) since 2009. We analyzed recurrence-free survival (RFS) rates estimated by the Kaplan\u2013Meier method in the patients classified into three groups: 1) total thyroidectomy (TTx) followed by lateral neck lymph node dissection (LLND) with RAI-a, 2) TTx\u2009+\u2009LLND without RAI-a, 3) hemithyroidectomy\u2009+\u2009LLND. In addition, propensity score analysis adjusted by\u00a0clinical parameters was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Two hundred eighty-eight patients with intermediate-risk PTC were identified. Among them, 87 patients with cN1b were analyzed.<\/jats:p>\n            <jats:p>Five-year RFS rates in 1), 2), and 3) groups were 85.0%, 100%, and 90.9%, respectively. The analysis of 1) and 2) groups by propensity score matching revealed 5-yr RFS rates of 84.1% and 100%, respectively (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0432).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>There was no evidence to support the use of 30\u00a0mCi (1.1GBq) radioactive iodine postoperatively to prevent recurrence in intermediate-risk PTC patients with cN1b.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12957-025-03912-0","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T06:01:22Z","timestamp":1751522482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach"],"prefix":"10.1186","volume":"23","author":[{"given":"Kiyomi","family":"Horiuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juro","family":"Yanagida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Omi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"7","key":"3912_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1507\/endocrj.EJ20-0025","volume":"67","author":"Y Ito","year":"2020","unstructured":"Ito Y, Onoda N, Okamoto T. The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer. Endocr J. 2020;67(7):669\u2013717.","journal-title":"Endocr J"},{"issue":"10","key":"3912_CR2","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1007\/s00268-023-07073-7","volume":"47","author":"K Horiuchi","year":"2023","unstructured":"Horiuchi K, Fujimoto M, Hidenori K, Yoshida Y, Noguchi E, Omi Y, et al. Outcomes of Patients with an Intermediate-Risk Group According to the Japanese Risk Classification of Papillary Thyroid Carcinoma. World J Surg. 2023;47(10):2464\u201373.","journal-title":"World J Surg"},{"issue":"2","key":"3912_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s12149-019-01432-y","volume":"34","author":"K Abe","year":"2020","unstructured":"Abe K, Ishizaki U, Ono T, Horiuchi K, Kanaya K, Sakai S, et al. Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer. Ann Nucl Med. 2020;34(2):144\u201351.","journal-title":"Ann Nucl Med"},{"issue":"4","key":"3912_CR4","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s00268-006-0455-0","volume":"31","author":"Y Ito","year":"2007","unstructured":"Ito Y, Miyauchi A, Jikuzono T, Higashiyama T, Takamura Y, Miya A, et al. Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC\/AJCC TNM classification and stage grouping. World J Surg. 2007;31(4):838\u201348.","journal-title":"World J Surg"},{"issue":"11","key":"3912_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00268-004-7644-5","volume":"28","author":"Y Ito","year":"2004","unstructured":"Ito Y, Tomoda C, Uruno T, et al. Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg. 2004;28(11):1115\u201320.","journal-title":"World J Surg"},{"issue":"5","key":"3912_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s00268-004-7192-z","volume":"28","author":"Y Ito","year":"2004","unstructured":"Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, et al. Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg. 2004;28(5):498\u2013501.","journal-title":"World J Surg"},{"issue":"7","key":"3912_CR7","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/hed.27067","volume":"44","author":"W Dong","year":"2022","unstructured":"Dong W, Horiuchi K, Noguchi E, Okamoto T. Predictive value of metastatic lateral lymph node ratio for recurrence in pathologically lateral lymph node-positive papillary thyroid cancer patients with palpable lymph nodes. Head Neck. 2022;44(7):1623\u201330.","journal-title":"Head Neck"},{"issue":"3","key":"3912_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/SLA.0b013e31814697d9","volume":"246","author":"KY Bilimoria","year":"2007","unstructured":"Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti AS, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007;246(3):375\u201381 discussion 381\u20134.","journal-title":"Ann Surg"},{"issue":"10","key":"3912_CR9","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.4158\/EP-2020-0125","volume":"26","author":"Z Wang","year":"2020","unstructured":"Wang Z, Xiang J, Gui Z, Qin Y, Sun W, Huang J, et al. Unilateral Tnm T1 And T2 Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: Total Thyroidectomy or Lobectomy? Endocr Pract. 2020;26(10):1085\u201392.","journal-title":"Endocr Pract"},{"issue":"4","key":"3912_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/SLA.0000000000000925","volume":"260","author":"MA Adam","year":"2014","unstructured":"Adam MA, Pura J, Gu L, Dian MA, Tyler DS, Reed SD, et al. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg. 2014;260(4):601\u20135 discussion 605\u20137.","journal-title":"Ann Surg"},{"issue":"5","key":"3912_CR11","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.surg.2017.12.026","volume":"163","author":"SR Rajjoub","year":"2018","unstructured":"Rajjoub SR, Yan H, Calcatera NA, Kuchta K, Wang CE, Lutfi W, et al. Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers. Surgery. 2018;163(5):1134\u201343.","journal-title":"Surgery"},{"key":"3912_CR12","unstructured":"Hulley SB, Cummings SR, Browner WS, et al. In: Designing Clinical Research. Wolters Kluwer Lippincott \/Williams & Wilkins Co.Pte.Ltd.: Philadelphia; 2013; pp.126\u20139"},{"issue":"1","key":"3912_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikigorov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid"},{"issue":"9","key":"3912_CR14","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1089\/thy.2022.0109","volume":"32","author":"A Papachristos","year":"2022","unstructured":"Papachristos A, Do K, Tsang VH, Sywak M, Gill AJ, Sidhu S, et al. Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy. Thyroid. 2022;32(9):1086\u201393.","journal-title":"Thyroid"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03912-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03912-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03912-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T06:01:23Z","timestamp":1751522483000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03912-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3912"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03912-0","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"25 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board of Tokyo Women\u2019s Medical University approved this clinical study (# 2021\u20130174), and it was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}